Cure My Disease

Don't miss your cure!

 Log in / Sign up

New shot aims to slash bad cholesterol after cardiac crises

NCT ID NCT06501443

Recruiting now Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study is testing if adding a new injectable cholesterol drug (inclisiran) to standard care helps patients better control their 'bad' cholesterol (LDL-C) after a recent heart attack, stroke, or urgent heart procedure. It will involve about 520 patients in Latin America who are in the hospital and stable. The main goal is to see if the new drug leads to greater cholesterol reduction over 11 months compared to standard care alone.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLAEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

Locations

  • Novartis Investigative Site

    RECRUITING

    Corrientes, W3400CDS, Argentina

  • Novartis Investigative Site

    RECRUITING

    Salvador, Estado de Bahia, 40170-130, Brazil

  • Novartis Investigative Site

    RECRUITING

    Belo Horizonte, Minas Gerais, 30000, Brazil

  • Novartis Investigative Site

    RECRUITING

    Belo Horizonte, Minas Gerais, 30110-934, Brazil

  • Novartis Investigative Site

    RECRUITING

    Campo Largo, Paraná, 83606-177, Brazil

  • Novartis Investigative Site

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90560-032, Brazil

  • Novartis Investigative Site

    WITHDRAWN

    Blumenau, Santa Catarina, 89010-500, Brazil

  • Novartis Investigative Site

    RECRUITING

    São José, Santa Catarina, 88103-901, Brazil

  • Novartis Investigative Site

    RECRUITING

    São José, São Paulo, 15015-110, Brazil

  • Novartis Investigative Site

    RECRUITING

    Campina Gde Do Sul, 83430 000, Brazil

  • Novartis Investigative Site

    RECRUITING

    Salvador, 40323-010, Brazil

Conditions

Explore the condition pages connected to this study.

HYPERCHOLESTEROLAEMIA